2009 Presidential Address: Mentoring … Touching the Future by Robertson, R. Paul
2009 Presidential Address: Mentoring...
Touching the Future
R. PAUL ROBERTSON, MD
M
entoring may be the most impor-
tantthingwedoonadailybasis.It
produces some of our greatest ex-
periments and successes, our mentees
themselves. Ironically, although we are
fond of publishing data from diabetes re-
search,weneverpublishtheresultsofour
mentoring in contemporary literature.
We must turn to oral and written history
to even deﬁne the word “mentoring.”
What exactly is it?
A modestly revised version of Greek
mythology
The word “mentor” evolved from Hom-
er’sopus,TheOdyssey.Odysseus(orUlys-
ses, his other name) was a graduate of
Cornell University and became King of
Ithaca.Hewasveryconﬂictedaboutﬁght-
ing the Trojan War. To avoid going to
battle, he pretended to be crazy by plow-
inghisﬁeldwithsalt.However,theGreek
military was suspicious and tested Odys-
seus by putting his newly born son,
Telemachus, in front of his plow. Odys-
seus stopped plowing to save his son.
Having thus demonstrated his sanity and
blown his cover, Odysseus joined the
army and sailed up the wine-dark Aegean
Sea to Troy where he entered graduate
school in the Greek War College. His re-
search project was to ascertain the effect
ofwoodenhorsesonwarfare.Beforeleav-
ingIthaca,Odysseushadaskedanelderly
friendnamedMentortoprovideadviceto
Telemachus, as well as to his lovely wife
Penelope.
After ﬁghting the Trojans for 10 years
and defeating them, Odysseus received
his ﬁrst patent for inventing the Trojan
horse and in many other ways distin-
guished himself in wisdom and leader-
ship. He received his PHD in Creative
Combat and then started out on his vic-
torious trip home, sailing south and see-
ingthesightsintheAegeanSea.However,
he encountered storms, took several
wrong turns, and wound up traveling
around the southern Mediterranean, Tyr-
rhenian, and Ionian seas for 10 more
years. This became his ﬁrst postdoctoral
experience. During his travels he escaped
the lethargic land of the Lotus eaters in
Tunisia; conquered Cyclops, a Sicilian
monster; confounded sirens off the coast
of Italy by having himself tied to the mast
and putting wax in his sailors’ ears; and
escaped a six-headed monster in the
straits of Messina. Finally, he made his
way back home to Ithaca disguised as a
beggar.
Faithful Penelope had been ﬁghting
off unwelcome suitors those 20 years and
failed to recognize Odysseus at ﬁrst when
he returned. But his faithful old dog did,
wagged his tail, and promptly dropped
dead of old age. Odysseus then identiﬁed
himself to his family and to Mentor. To-
gether they hatched a plot to get rid of the
suitors.Penelopefetchedanoldbowused
byOdysseusandchallengedhersuitorsto
demonstrate their prowess with it. You
can see the happy ending coming. None
ofthesuitorswerestrongenoughtostring
the bow. Odysseus did so easily and with
it killed Penelope’s suitors. Like a true
mentor, the good counselor Mentor sim-
ply faded into the background and took
no credit.
Diabetologists as mentors
What does all this have to do with men-
toring within the American Diabetes As-
sociation (ADA)? As scientists, clinicians,
educators, and health care providers, we
mentor all day long. We train younger
professionals who come into our labs,
clinics, and classrooms. They come to
learn theory and procedures. They seek
our words of wisdom on all sorts of
things: how to properly form and test hy-
potheses, how to run a gel; how to pro-
gram an insulin pump, how to juggle
drugs to prod our patients’ sluggish
-cells, how to formulate optimal diets
for our patients, and how to educate the
public about social and ﬁnancial impacts
of diabetes. Senior mentees next begin to
mentor junior mentees—students and
patients—andthusthecycleofmentoring
is played forward. Then an amazing thing
happens. The very people we are mentor-
ing begin to mentor us. There is a name
for this: reverse mentoring. Students and
fellowsbringusnewinformationfromthe
Internet. On rare and miraculous occa-
sions of unguarded curiosity when their
computers are down, they even go to li-
braries and ﬁnd information for us from
real, rather than virtual, journals.
Many of us have the special privilege
of mentoring diabetic patients and their
families. We serve as coaches for these
truly impressive athletes as they struggle
with, adapt to, and overcome major chal-
lenges that never seem to relent. If we lis-
ten carefully, they also mentor us. They
often teach us ways they have discovered
to better control their personal glycemic
swings. They help us to understand that
today’s improved methods of diabetes
care are not always available to all people
in all cultures.
Perhaps the most intense mentoring
we experience comes in the form of study
sections,manuscriptreviews,andaccred-
itation committees. Admittedly, these ex-
periencesmaynotbealwaysthoughtofas
mentoring—maybe some other kind of
experience. Perhaps they represent our
own Greek odyssey ﬁlled with perceived
monsters and dangers such as conﬂicts of
interest, professional jealousies, passive
aggressiveness, or at best just plain ob-
tuseness. As an example, think again of
Odysseus tied to the mast, feeling help-
less. Perhaps he has just submitted his
proposal for a junior faculty award. The
studysectionrowinghisboatstillhaswax
in the ears and does not appear to be
listening.
But, in truth, scientiﬁc peer review
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inprofessionallife.Myfriendsinthebusi-
ness world are amazed by this. What
group of businessmen would agree to re-
view their colleagues’ work with a ﬁne-
tooth comb, climb onto airplanes to ﬂy to
Washington DC, and then spend days
away from their families and their own
work to provide valuable consultation?
All this with no signiﬁcant ﬁnancial com-
pensation. Surely, we are a unique group
of professionals mentoring and teaching
fellow professionals, which brings me to
this year’s Scientiﬁc Sessions.
Sixty-nine years of annual medicine:
science meetings
This annual migration of people inter-
ested in diabetes began 69 years ago. The
ﬁrst ADA Scientiﬁc Sessions was held in
Cleveland, Ohio, in 1941, with 250 phy-
sicians in attendance at the Hotel Hol-
lenden (it is curious but noteworthy that
Cleveland is located just southwest of a
town called Mentor in northeastern
Ohio).Theprogramlistedagrandtotalof
ﬁve presentations. Of interest, it was 14
years later, in 1955, that ADA awarded its
ﬁrst two research fellowships to two
young scientists. One of them worked in
the laboratory of Dr. Albert Renold. To-
day, in his memory, the ADA annually
grants a prestigious award for mentoring,
the Albert Renold Medal. By the mid-
1960s, diabetes had tripled in incidence
compared with 20 years previously—
sounds similar to today’s epidemiologic
trends. The book entitled The Journey and
the Dream, a history of ADA, tells us that
in1970ADAreorganizedintoavoluntary
health agency with the primary goal of
fundingresearch.Thatphraseisworthre-
peating: with the primary goal of funding
diabetes research. When I presented my
ﬁrst ADA talk in 1972 in San Francisco,
California, the audience ﬁt into two
rooms in the Sheraton Palace Hotel. The
program consisted of 62 talks and 108
abstracts, and poster sessions were
nonexistent.
Things look very different these days.
I don’t have all the data for this year’s Sci-
entiﬁc Sessions, but here is how they
looked last year, in 2008:
● Pages in the meeting program: 1,034
● Abstracts presented orally: 397
● Total abstracts submitted: 2,879
● Attendance: 20,562
● Attendees from the Americas: 59%
● Attendees from Europe: 35%
● Attendees from Asia and the Paciﬁc:
6%
The medical and scientiﬁc progress
thatattractsustothismeetinghascomeat
a price. We now meet in gargantuan halls
that no hotel in Cleveland could accom-
modate. We encounter more strangers
than we greet familiar colleagues. The
GreekgodHermescomestomind.Weall
could use his winged feet, or at least track
shoes, to get from one session to another.
Our sheer size limits the number of cities
thatcanhandleus.Oldtimerssufferfrom
painful nostalgia of smaller meetings 40
years ago. Our Scientiﬁc Sessions is in-
creasingly confronted with enormity and
anonymity.
To keep a human dimension to this
large meeting, steps we have already
taken include keeping some interest
groups in one meeting room for most of
theScientiﬁcSessions.Doingthisconveys
the sense of a smaller meeting but still
enables attendees to go to the larger ses-
sions and exhibit hall. We are exploring
whether we should expand this concept
to other interest groups. Certainly, we do
not want to lose the opportunity to hear
what is going on in all areas related to
diabetes. We know that learning about
developments in one area of science often
gives us ideas about what we might do in
our own area of expertise. However, we
need to ﬁnd more effective ways of pro-
viding easier access for younger scientists
and clinicians to their more established
colleagues in a more social, user-friendly
environment.Thiswillfacilitateexchange
ofideasandexperiencesaswellasidentify
new academic and employment opportu-
nities for postdoctorate scholars and
faculty.
Working as one ADA
ImentionedearlierthatADAandtheﬁeld
ofdiabeteshavegrownenormouslyinthe
past 69 years. Yet the number of research
awards we give has barely grown at all.
Recognition of excellence is an important
aspect of our professional lives, so we
have begun to reexamine how we do it.
Recently, ADA has convened a dedicated
group that studied this issue, and it has
recommended an award process that will
morecompletelyrecognizetheexcellence
inourvariousdisciplines.Staytuned;you
will hear more about this later in the year.
Inotherimportantnews,wehavejust
begun a series of meetings with The En-
docrine Society. Our joint goal is to iden-
tify how we can work together to foster
qualitymedicalcareandtoinﬂuencepub-
lic policy issues. This seems only sensible
given our limited resources and the huge
amount of work in diabetes and obesity
we can tackle together.
This meeting is focused on reporting
progress in medicine and science, which
raises the question, what have we accom-
plished during all the years since 1941?
Thumbing through abstract books pub-
lishedoverthepast40yearsrelatesclearly
that the scientiﬁc and clinical material
presented at our meetings has greatly es-
calated in quality and quantity. Yet, the
cure of diabetes continues to elude us.
The current global epidemic of diabetes
tells us we are not winning this war. The
startling appearance of type 2 diabetes in
our youth alarms us. The parallel epi-
demic in obesity greatly compounds the
problem of diabetes. These incontrovert-
ible facts reinforce the obvious that we
must work harder, think more creatively,
and achieve our scientiﬁc goals more
quickly.
This is easily said but hard to do. Just
dreaming about accelerating diabetes re-
search will not do the job. A successful
responsetothesedemandswillcomeonly
at a price. We must seriously increase the
ﬁscal support of research provided by
ADA as well as all potential funding
sources to more vigorously fund research
that will allow us to overcome this dis-
ease. In terms of ADA funding, there is
good and bad news. The good news is we
have had a steep rise in research funding
sincethemid-1990s.Thebadnewsisthat
research support reached a plateau over
the past 4 years. Other good news is that
the number of grants funded by ADA has
not decreased over the past year, when
some organizations severely cut back
their funding of diabetes research alto-
gether.Theworstnewsisthatfundraising
by ADA and its investment portfolio have
been hit especially hard by the economy
in 2009. This has led to a layoff of ADA
staff nationally as well as a decrease in
funds available to support our research
program. Consequently, we had to do
something to manage this problem.
The choices for ADA research were to
stop funding new grants completely be-
ginning July 2009 or to ﬁnd a way to dis-
tribute less money evenly among all
grantees. The Executive Committee de-
cideditisjustnotacceptabletostopfund-
ingnewresearch.Therearetoomanynew
ideas, exciting opportunities, and excel-
lent diabetes investigators to permit this.
Consequently, our strategy will be to ad-
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new and current grants, in roughly the
samemannerwehaveseenattheNational
Institutes of Health over the past 2 years.
Thisiscertainlydiscouragingbutnotdev-
astating news. Although painful, this
strategy will allow us to ensure that the
ADA research program is still open for
business and still funding new research.
We will use the message that ADA is still
funding new research as a strong incen-
tive for greater fundraising so that we can
become ﬁnancially whole again.
Moreover, the Executive Committee
of ADA has resolved that as soon as the
economic situation at ADA recovers, the
ﬁrst program to be ﬁnancially restored
will be its research program. ADA recog-
nizes that we have come too far to falter.
We have had too many glimpses of cures
on the horizon to bog down in despair.
Weknowthatfailureisnotanoption.We
have trained too many young basic and
clinical scientists to abandon their fu-
tures,whichonceagainbringsmebackto
mentoring.
We as an organization and as individ-
ualsmustmentorsocietyandgovernment
about the need to fund diabetes research.
We need to let people know what it will
take to translate our scientiﬁc and clinical
knowledgeintopreventionandmoresuc-
cessful clinical management of diabetes.
Weneedtoeducateoneanotheraboutthe
massivestridesADAhasmadeinissuesof
advocacy for patients with diabetes and
their families. We need to appreciate and
support the ADA’s relentless efforts to
raise more money and make us a more
effective organization. We must remem-
ber that we are all colleagues on this
journey.
Ourbiggestfundraisingeventthrough-
out the nation takes place in October. Its
name is Step Out. We need to thank our
fundraisersforwhattheyhavedoneinthe
past and now ask them to work even
harder. Those of us from the U.S. need to
participatemorefullyinthesefundraising
events by walking further, golﬁng better,
biking longer, running faster, contacting
more potential donors, and digging
deeperintoourownpocketstofundADA
research.
The various interest groups in ADA
are major resources for our mission. They
have been immensely successful in many
ways. Yet, we are smart enough to realize
that we will get further faster by working
together as one large force to reach our
many objectives. Borrowing a page from
President Obama’s playbook, let me say
that the best plan is for there to be no
separate departments for Science and
Medicine ADA, no Fundraising ADA, no
Administration ADA, no Advocacy ADA,
and no Education and Health Care ADA.
The best plan is for there to be only one
ADA and that ADA is all of us working
together to do what we must do to gain
control over this disease and all its
complications.
Personal lessons learned from
mentees
I want to ﬁnish this address by focusing
on the futures of the younger scientists
and clinicians we have mentored. I have
been privileged to mentor many special
people at the Universities of Washington,
Colorado, and Minnesota. It is their hard
work and dedication that led to our pub-
lications. During all these years, I have
learned something special from each of
them:examplesofreversementoring.We
know that training and supporting young
people such as these have become in-
creasingly more complicated for a variety
of reasons. This makes our jobs as men-
tors even more essential. We know our
mentoring will provide more promise for
the future than anything else we can do.
We know that our greatest personal lega-
cies will be the provision of tomorrow’s
leaders.
This causes us to consider: what are
the characteristics of a successful mentor?
Here are some of the lessons my mentees
have taught me.
To mentor is:
● to be a selﬂess senior colleague
● to listen and understand personal and
professional dilemmas
● to teach mentees problem-solving
skills but, at the same time, refrain as
much as possible from solving prob-
lems for them
● to follow up on mentoring sessions to
hear outcomes of decisions made and
to consider alternative courses of ac-
tion when needed
● to guide ﬁrmly initially but increas-
ingly let go at the earliest opportunity
● to maintain strict conﬁdentiality
● to encourage and celebrate and to give
spontaneous hugs and high ﬁves
whenever and wherever warranted
● to understand that when serious per-
sonal interventions are needed, they
should be provided and although this
can be difﬁcult, to understand it is the
essence of being loyal
● to stand back and take quiet personal
pride in mentees’ successes and to
avoid taking any credit for them
● to suffer in silence around junior col-
leagueswhenone’sownpersonalprob-
lems with grant or manuscript reviews
plagueusandtofocusonencouraging,
not discouraging, the dedicated men
and women who come to us to learn
and to carry our batons and their
torches into the future
● above all, to always remember that, to
paraphrase astronaut Christa McCul-
lough’s inspiring words, when we
mentor, we touch the future. It can be
an awesome experience.
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